GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

It’s not at all clear what a tariff would mean for Novo, which manufactures its medicines in facilities all over the world, ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Kya Odom was forced to face a shocking truth after dropping 30 pounds in just over 30 days. Her face had deflated. So, to ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.